Microdosing Mushrooms: A Natural Anxiety Remedy?

Microdosing has gained popularity in recent years, with people turning to this practice to improve their mental health. Microdosing involves taking small amounts of psychedelic substances, such as psilocybin, the active ingredient in magic mushrooms, which are believed to improve mental health symptoms like anxiety and depression. While some studies suggest that microdosing mushrooms can help reduce anxiety, the evidence is limited due to the challenges of conducting controlled studies and the illegal status of psilocybin in most places.

Microdosing mushrooms may help reduce anxiety

While the use of regular doses of psilocybin can produce unpleasant and terrifying experiences, microdosing has been associated with improved mood and mental health. A large study showed that individuals who microdose psilocybin exhibited improved mood and a greater decline in anxiety, depression, and stress over a one-month period than those who did not microdose.

Additionally, microdosers were found to have lower levels of dysfunctional attitudes and negative emotionality, as well as higher levels of wisdom, open-mindedness, and creativity compared to non-microdosers. Microdosing psilocybin can also lead to improved cognitive function and enhanced mood, which can help alleviate symptoms of anxiety and depression.

However, it is important to note that there are also potential challenges and side effects associated with microdosing mushrooms. Some people may experience physiologic discomfort, increased anxiety, insomnia, poor mood, low energy, physical discomfort, poor focus, and impaired social skills. It is also important to consider the legality and safety of microdosing mushrooms, as true psilocybin mushrooms can be hard to come by and some poisonous mushrooms look similar to psilocybin-containing mushrooms.

Microdosing mushrooms may improve mood and cognitive function

Microdosing psychedelics has gained popularity in recent years, with a growing body of evidence suggesting a positive correlation between the practice and improved mental well-being. While research is still ongoing, there are indications that microdosing mushrooms may indeed improve mood and cognitive function, with potential benefits for individuals experiencing anxiety.

The active ingredient in magic mushrooms, psilocybin, has been the focus of numerous studies investigating its effects on mental health. In one such study, researchers analysed responses from 410 people worldwide with mental or physical health diagnoses and experience with psychedelics, most commonly mushrooms. This research suggested that microdoses of psychedelics were considered more effective than prescription medications in treating anxiety, though full doses were generally viewed as more effective. Another study, involving 953 microdosers of psilocybin and 180 non-microdosers, found that the former group exhibited improved mood and a greater decline in anxiety, depression, and stress over a one-month period.

The classification of psilocybin as a drug of abuse without medical value has hindered therapeutic research in the past. However, the resurgence of interest in the potential of psychedelic drugs for treating mental health conditions, including anxiety, has led to promising findings. For instance, a 2020 analysis of four small studies concluded that psilocybin combined with psychotherapy may be safe and effective for improving anxiety, depression, and existential distress in individuals with life-threatening illnesses.

It is important to note that the effects of microdosing mushrooms may vary depending on individual factors, and some studies have reported mixed results. While some users report improved mood and cognitive function, others have experienced increased anxiety, insomnia, and physical discomfort. Additionally, psilocybin is not recommended for individuals with psychotic conditions or severe forms of bipolar disorder and borderline personality disorder.

Overall, while the research is still evolving, there is preliminary evidence to suggest that microdosing mushrooms may improve mood and cognitive function, offering potential benefits for individuals seeking relief from anxiety. However, more rigorously designed clinical trials are needed to establish the efficacy and safety of this practice conclusively.

Microdosing mushrooms may reduce depression

Microdosing psychedelics, such as lysergic acid diethylamide (LSD) and psilocybin, has been associated with improved mental well-being. Psilocybin is the active ingredient in magic mushrooms, and microdosing it has been shown to have potential benefits for mental health.

A large study has shown that individuals who microdose psilocybin exhibit improved mood and a greater decline in anxiety, depression, and stress over a one-month period compared to those who do not microdose. This study, conducted by Joseph Rootman, a doctoral student at the University of British Columbia, is the largest longitudinal study on microdosing psilocybin to date and one of the few to include a control group. The results of this study add to the growing body of research suggesting a positive correlation between microdosing psilocybin and improved mental health.

Psilocybin has been used for its beneficial health effects for thousands of years. However, its classification as a drug of abuse without any medical use has hindered research on its therapeutic effects. In recent years, there has been a resurgence of interest in the potential use of psilocybin for treating depression, anxiety, and post-traumatic stress.

While the evidence supporting the use of psilocybin for depression is still limited due to its illegal status, research suggests that it may help relieve feelings of depression and improve general well-being. Additionally, psilocybin acts on the body's serotoninergic system, which could help restore serotonin balance. Serotonin imbalance is associated with anxiety and depression.

It is important to note that microdosing psilocybin may not be safe for everyone. It is not recommended for people with psychotic conditions, and it can cause adverse effects such as insomnia, increased anxiety, and physical discomfort. Furthermore, some poisonous mushrooms resemble psilocybin-containing mushrooms, and ingesting them can be fatal. Therefore, it is crucial to exercise caution and seek professional guidance before considering microdosing psilocybin.

Microdosing mushrooms may reduce stress

Research suggests that microdosing psilocybin can improve cognitive function and enhance mood. A large study found that individuals who microdosed psilocybin showed improved mood and a greater decline in anxiety, depression, and stress over a one-month period compared to those who did not microdose. This adds to the growing body of research that suggests positive benefits of microdosing on mental health and cognition.

Some people combine psilocybin with other substances, such as Lion's Mane mushrooms, chocolate, and niacin, in a practice known as "stacking." Niacin is thought to improve the absorption of psilocybin and could potentially enhance its effects. Microdosers who combined psilocybin with Lion's Mane mushrooms reported lower levels of depression, anxiety, and stress compared to non-microdosers.

While microdosing psilocybin may offer potential benefits for stress reduction and improved mental health, it is important to note that the research in this area is still evolving. Some studies have reported challenges and side effects associated with microdosing, such as physiologic discomfort, increased anxiety, and insomnia. Additionally, the safety and effectiveness of microdosing are not yet fully understood, and it may not be suitable for everyone. Further rigorously designed clinical trials are needed to establish a causal relationship between microdosing and improvements in mental health.

Microdosing mushrooms may improve daily function

Microdosing psychedelics, such as lysergic acid diethylamide (LSD) and psilocybin, has been associated with a range of potential benefits, including improved daily function. Psilocybin is the active ingredient in magic mushrooms and has been used for its beneficial health effects for thousands of years.

While the use of full doses of psilocybin has been shown to decrease feelings of anxiety and depression, the effects of microdosing have only recently been studied. Microdosing involves consuming small amounts of psychedelic substances that do not produce hallucinogenic effects. Typically, microdosers use about 10% of the regular dose of psilocybin, equivalent to about 100-300 milligrams of dried mushrooms, between 2-5 times a week.

Some people microdose with psilocybin-containing mushrooms to improve mental health symptoms such as anxiety and depression. While evidence supporting this use is limited, likely due to the illegal status of psilocybin in many places, some studies have shown that microdosing psilocybin can improve cognitive function and enhance mood, in addition to reducing symptoms of anxiety and depression. For example, a large study showed that individuals who microdosed psilocybin exhibited improved mood and a greater decline in anxiety, depression, and stress over a one-month period compared to those who did not microdose.

Additionally, microdosers have reported lower levels of anxiety and depression compared to non-microdosers, and some studies have observed that positive expectations about microdosing can lead to more positive outcomes. However, it is important to note that the causal relationship between microdosing and mental health improvements remains uncertain due to the limited number of controlled studies and small sample sizes in some cases. Furthermore, microdosing psilocybin may not be suitable for everyone, as it can lead to insomnia, increased anxiety, and other side effects in certain individuals.

Frequently asked questions